.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint asks for introduction of people with MASLD and also dimension of liver end results in cardio-- kidney-- metabolic trials, when data advise mechanistically conceivable benefits and also medical safety and security-- and also details considerations for test layout and also regulative commendation.